Please clarify the reason of the increase in allocation for COS and G&A on employee costs (i.e. USD 3.1m and USD 1.4m respectively) - as employee costs for COS should be variable and increase accordingly to the increase of the sales volume of 31% and G&A - Employee costs should be fixed and remained the same as FY19 assuming that there's no increase in headcount